Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Acta Physiologica Sinica ; (6): 461-468, 2022.
Article in Chinese | WPRIM | ID: wpr-939580

ABSTRACT

Histone methylation is one of the key post-translational modifications that plays a critical role in various heart diseases, including diabetic cardiomyopathy. A great deal of evidence has shown that histone methylation is closely related to hyperglycemia, insulin resistance, lipid and advanced glycation end products deposition, inflammatory and oxidative stress, endoplasmic reticulum stress and cell apoptosis, and these pathological factors play an important role in the pathogenesis of diabetic cardiomyopathy. In order to provide a novel theoretical basis and potential targets for the treatment of diabetic cardiomyopathy from the perspective of epigenetics, this review discussed and elucidated the association between histone methylation and the pathogenesis of diabetic cardiomyopathy in details.


Subject(s)
Humans , Diabetes Mellitus , Diabetic Cardiomyopathies/pathology , Histones , Methylation , Oxidative Stress , Protein Processing, Post-Translational
2.
Braz. J. Pharm. Sci. (Online) ; 58: e19652, 2022. tab, graf
Article in English | LILACS | ID: biblio-1384005

ABSTRACT

Abstract Background and aim: Stingless bee propolis, a resinous compound processed by mandibular secretion of stingless bees, is used for maintenance of hygiene and stability of beehives. Research on stingless bee propolis shows therapeutic properties attributed to polyphenols exhibiting antioxidative, antihyperglycemic and antiischemic effect. However, the cardioprotective effect of stingless bee propolis on diabetic cardiomyopathy is unknown. Methods: Adult male Sprague Dawley rats were randomised to five groups: normal group, diabetic group, diabetic given metformin (DM+M), diabetic given propolis (DM+P) and diabetic given combination therapy (DM+M+P) and treated for four weeks. Body weight, fasting blood glucose, food and water intake were taken weekly. At the end of experiment, biomarkers of oxidative damage were measured in serum and heart tissue. Antioxidants in heart tissue were quantified. Part of left ventricle of heart was processed for histological staining including Haematoxylin and Eosin (H&E) stain for myocyte size and Masson's Trichrome (MT) stain for heart fibrosis and perivascular fibrosis. Results: Propolis alleviated features of diabetic cardiomyopathy such as myocyte hypertrophy, heart fibrosis and perivascular fibrosis associated with improvement in antioxidative status. Conclusion: This study reports beneficial effect of propolis and combination with metformin in alleviating histopathological feature of diabetic cardiomyopathy by modulating antioxidants, making propolis an emerging complementary therapy.


Subject(s)
Animals , Male , Rats , Propolis/adverse effects , Bees/classification , Diabetic Cardiomyopathies/pathology , Staining and Labeling/instrumentation , Blood Glucose/metabolism , Rats, Sprague-Dawley/classification , Cardiomegaly/pathology , Eosine Yellowish-(YS) , Drinking , Heart Ventricles/abnormalities , Hypoglycemic Agents , Metformin/agonists , Antioxidants/adverse effects
3.
Braz. j. med. biol. res ; 50(8): e6204, 2017. tab, graf
Article in English | LILACS | ID: biblio-888983

ABSTRACT

Oxidative stress plays an important role in the development of diabetic cardiomyopathy. In the present study, we determined whether the effect of astragalus polysaccharides (APS) on diabetic cardiomyopathy was associated with its impact on oxidative stress. Streptozotocin (STZ)-induced diabetic mice and heterozygous superoxide dismutase (SOD2+/-) knockout mice were administered APS. The hemodynamics, cardiac ultrastructure, and the apoptosis, necrosis and proliferation of cardiomyocytes were assessed to evaluate the effect of APS on diabetic and oxidative cardiomyopathy. Furthermore, H2O2 formation, oxidative stress/damage, and SOD activity in cardiomyocytes were evaluated to determine the effects of APS on cardiac oxidative stress. APS therapy improved hemodynamics and myocardial ultrastructure with reduced apoptosis/necrosis, and enhanced proliferation in cardiomyocytes from both STZ-induced diabetic mice and heterozygous SOD2+/- knockout mice. In addition, APS therapy reduced H2O2 formation and oxidative stress/damage, and enhanced SOD activity in both groups of mice. Our findings suggest that APS had benefits in diabetic cardiomyopathy, which may be partly associated with its impact on cardiac oxidative stress.


Subject(s)
Animals , Male , Mice , Polysaccharides/therapeutic use , Superoxide Dismutase/genetics , Plant Extracts/therapeutic use , Astragalus Plant/chemistry , Diabetes Mellitus, Experimental/drug therapy , Diabetic Cardiomyopathies/drug therapy , Apoptosis/drug effects , Streptozocin , Mice, Knockout , Oxidative Stress/drug effects , Myocytes, Cardiac/drug effects , Myocytes, Cardiac/ultrastructure , Microscopy, Electron, Transmission , Cell Proliferation/drug effects , Diabetes Mellitus, Experimental/pathology , Diabetic Cardiomyopathies/pathology , Mice, Inbred C57BL
SELECTION OF CITATIONS
SEARCH DETAIL